You have 9 free searches left this month | for more free features.

City

Bethesda (1)

Condition

Autosomal Dominant Hypocalcemia (ADH) (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Calcilytix Therapeutics, Inc., a BridgeBio company (1)

Collaborator

Intervention

cltx-305 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

cltx-305

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Autosomal Dominant Hypocalcemia (ADH) Trial run by the (CLTX-305)

Active, not recruiting

Autosomal Dominant Hypocalcemia (ADH)

CLTX-305

Bethesda, Maryland

National Institute of Health

Jul 20, 2022